Leaning into the immune system’s complexity
By designing new tools that can analyze huge libraries of immune cells and their targets, Michael Birnbaum hopes to generate better T cell therapies for cancer and other diseases.
Koch Institute
Professor Emerita Mary-Lou Pardue, pioneering cellular and molecular biologist, dies at 90
Known for her rigorous approach to science and her influential research, Pardue paved the way for women in science at MIT and beyond.
Nancy Kanwisher, Robert Langer, and Sara Seager named Kavli Prize Laureates
MIT scientists honored in each of the three Kavli Prize categories: neuroscience, nanoscience, and astrophysics, respectively.
Catalyst Symposium helps lower “activation barriers” for rising biology researchers
Second annual assembly, sponsored by the Department of Biology and Picower Institute, invited postdocs from across the country to meet with faculty, present their work to the MIT community, and build relationships.
New technique reveals how gene transcription is coordinated in cells
By capturing short-lived RNA molecules, scientists can map relationships between genes and the regulatory elements that control them.
“Rosetta Stone” of cell signaling could expedite precision cancer medicine
An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.
Circadian rhythms can influence drugs’ effectiveness
MIT researchers find circadian variations in liver function play an important role in how drugs are broken down in the body.
A closed-loop drug-delivery system could improve chemotherapy
New CLAUDIA system could continuously monitor patients during an infusion and adjust dosage to maintain optimal drug levels.
Women in STEM — A celebration of excellence and curiosity
An MIT Values event showcased three women's career journeys and how they are paving the way for the next generation.
MIT tops among single-campus universities in US patents granted
For 10th consecutive year, the Institute ranks No. 2 among all colleges and No. 1 among colleges with one main campus, underlying the impact of innovation and critical role of technology transfer.
Tackling cancer at the nanoscale
In MIT’s 2024 Killian Lecture, chemical engineer Paula Hammond described her groundbreaking work on nanoparticles designed to attack tumor cells.
Five MIT faculty members take on Cancer Grand Challenges
Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.
Scientists develop a rapid gene-editing screen to find effects of cancer mutations
With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.
MIT scientists use a new type of nanoparticle to make vaccines more powerful
Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at a lower dose.
How early-stage cancer cells hide from the immune system
A new study finds precancerous colon cells turn on a gene called SOX17, which helps them evade detection and develop into more advanced tumors.